The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
TTD: Therapeutic Target Database
Open accessAbstract
A number of proteins and nucleic acids have been explored as therapeutic targets. These targets are subjects of interest in different areas of biomedical and pharmaceutical research and in the development and evaluation of bioinformatics, molecular modeling, computer-aided drug design and analytical tools. A publicly accessible database that provides comprehensive information about these targets is therefore helpful to the relevant communities. The Therapeutic Target Database (TTD) is designed to provide information about the known therapeutic protein and nucleic acid targets described in the literature, the targeted disease conditions, the pathway information and the corresponding drugs/ligands directed at each of these targets. Cross-links to other databases are also introduced to facilitate the access of information about the sequence, 3D structure, function, nomenclature, drug/ligand binding properties, drug usage and effects, and related literature for each target. This database can be accessed at http://xin.cz3.nus.edu.sg/group/ttd/ttd.asp and it currently contains entries for 433 targets covering 125 disease conditions along with 809 drugs/ligands directed at each of these targets. Each entry can be retrieved through multiple methods including target name, disease name, drug/ligand name, drug/ligand function and drug therapeutic classification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules
Cornell, W. D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, K. M., Ferguson, D. M., Spellmeyer, D. C., Fox, T., Caldwell, J. W., & Kollman, P. A. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00124a002 · Cited by 13,103
The SWISS-PROT protein sequence data bank and its supplement TrEMBL
Bairoch, A., & Apweiler, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.1.31 · Cited by 3,587
The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1998
Bairoch, A. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.38 · Cited by 3,280
The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000
Bairoch, A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.45 · Cited by 3,093
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Bairoch, A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.304 · Cited by 1,129
Mechanism-Based Target Identification and Drug Discovery in Cancer Research
Gibbs, J. B. (2000) · Science · doi:10.1126/science.287.5460.1969 · Cited by 606
Mitochondrial Targets of Drug Toxicity
Wallace, K. B., & Starkov, A. A. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.353 · Cited by 464
Dissecting Human Disease in the Postgenomic Era
Peltonen, L., & McKusick, V. A. (2001) · Science · doi:10.1126/science.291.5507.1224 · Cited by 415
Chen, Y. Z., & Zhi, D. G. (2001) · Proteins: Structure, Function, and Genetics · doi:10.1002/1097-0134(20010501)43:2<217::aid-prot1032>3.0.co;2-g · Cited by 353
Serhan, C. N. (1996) · Nature · doi:10.1038/384023a0 · Cited by 234
100,000 protein structures for the biologist
Šali, A. (1998) · Nature Structural Biology · doi:10.1038/4136 · Cited by 223
Beyond complete genomes: from sequence to structure and function
Koonin, E. V., Tatusov, R. L., & Galperin, M. Y. (1998) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(98)80070-5 · Cited by 164
An Overview of Chemotherapeutic Targets for Antimalarial Drug Discovery
Olliaro, P., & Yuthavong, Y. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00036-9 · Cited by 150
Drug Discovery in the Next Millennium
Ohlstein, E. H., Ruffolo, R. R., Jr., & Elliott, J. D. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.177 · Cited by 128
Tumor angiogenesis—new drugs on the block
Brower, V. (1999) · Nature Biotechnology · doi:10.1038/13654 · Cited by 125
PubMed: bridging the information gap.
McEntyre, J., & Lipman, D. J. (2001) · PubMed · Cited by 113
Genomics and Antimicrobial Drug Discovery
Moir, D. T., Shaw, K. J., Hare, R. S., & Vovis, G. F. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.439 · Cited by 106
Advances in Pharmacogenetics and Pharmacogenomics
Vesell, E. S. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022009666 · Cited by 68
Use of structural information in drug design
Navia, M. A., & Murcko, M. A. (1992) · Current Biology · doi:10.1016/0960-9822(92)90500-a · Cited by 19
Cited by
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
A comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427
Molecular Docking: Shifting Paradigms in Drug Discovery
Pinzi, L., & Rastelli, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184331 · Cited by 2,344
Metadata
- Authors
- Chen, X.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-01-01
- Volume
- 30
- Issue
- 1
- Pages
- 412-415
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2034537627
- Cited by
- 716
- References
- 21
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.